|
|
News Releases
December 14, 2009
Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 
December 2, 2009
First Lesion-localization System for Molecular Breast Imaging Proves to Be Highly Effective for Gamma-Guided Biopsy: Results Presented Today at RSNA
November 30, 2009
BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings (Bertrand)
November 30, 2009
Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ (Brem)
November 30, 2009
Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging For Biopsy (Rapelyea)
November 30, 2009
Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer (Torrente)
November 19, 2009
Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI)
October 13, 2009
New Hope: Breast Cancer Detection Goes Beyond Mammography to See What Matters
October 11, 2009
Dilon Diagnostics Joins Forces With Philips for Women's Health Solutions
October 8, 2009
Breast Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis
April 9, 2009
Further Testing with Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management
April 9, 2009
Breast-Specific Gamma Imaging (BSGI) Study Receives Breast Journal Abstract Award
March 18, 2009
Breast-Specific Gamma Imaging (BSGI) Can Reduce the Number of Unnecessary Breast Biopsies When Compared to MRI
March 18, 2009
In Women Over the Age of 65, Breast-Specific Gamma Imaging (BSGI) Limits Biopsies, Costs for Diagnosing Breast Cancer
March 3, 2009
Breast-Specific Gamma Imaging (BSGI) Offers Greater Sensitivity Over Mammography, Ultrasound and MRI
February 27, 2009
Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer In Newly Diagnosed Breast Cancer Patients
February 10, 2009
Dilon Technologies Leads Molecular Breast Imaging Expansion
February 3, 2009
Dilon Technologies’ Slant15™ and LEHR Collimators Enhance Imaging Capabilities
December 3, 2008
Molecular Breast Imaging Outperforms MRI for Patients with Inconclusive Results in the Diagnosis of Cancer
December 3, 2008
Molecular Breast Imaging Identifies Occult Cancer
December 2, 2008
Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI For Invasive Lobular Carcinoma
December 1, 2008
Molecular Breast Imaging Offers A Clear Look Beyond Mammography, MRI and Ultrasound Studies to be Presented at the RSNA
December 1, 2008
Molecular Breast Imaging Proves Cost-Effective for Presurgical Planning In Patients with Breast Cancer
December 1, 2008
Molecular Breast Imaging Performs Better than Ultrasound in Patients with Mammographic Abnormalities
November 18, 2008
Dilon Technologies Forms Alliance with Terason Ultrasound To Offer Expanded Diagnostic Imaging Options
November 6, 2008
Dilon Technologies Partners with PenRad Mammography Information Systems to Provide Streamlined Diagnostic Analysis and Reporting
September 29, 2008
Dilon Technologies Appoints New Corporate Controller
September 25, 2008
First Accredited CME Course on BSGI – The Molecular Breast Imaging Exam, Now Available to All Physicians
September 4, 2008
Molecular Breast Imaging Is Found to Provide More Conclusive Results Than Breast MRI
August 12, 2008
Dilon Technologies Announces a Transportable Version of the Dilon 6800 Gamma Camera
July 16, 2008
Dilon Technologies signs Amerinet for Breast-Specific Gamma Imaging
July 1, 2008
Solis Women's Health Brings Molecular Breast Imaging to Dallas-Forth Worth Metroplex
June 19, 2008
Dilon Technologies Announces Agreement with MedAssets
June 9, 2008
Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients with Known Diagnosis
May 29, 2008
Breast-Specific Gamma Imaging (BSGI) Found to be Highly Sensitive for Early Stage Breast Cancer
May 06, 2008
Dilon Technologies Receives CE Mark for Medical Imaging System
April 29, 2008
Community Breast Center Experience Shows "Real-World" Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
April 11, 2008
Dilon Technologies Closes First Quarter with Record Sales
March 12, 2008
To Better Manage Suspicious Breast Lesions Detected on Breast MRI, There is Significant Value in Utilizing Breast-Specific Gamma Imaging
March 5, 2008
Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
February 7, 2008
Newly Appointed Dilon Technologies President & CEO Robert G. Moussa: Sees BSGI as "...Major weapon in the battle against cancer"
|
|
